Phase II trial of carboplatin (C) and bevacizumab (BEV) in patients (pts) with breast cancer brain metastases (BCBM).

被引：1
|
作者：
Lin, Nancy U.
Gelman, Rebecca Sue
Younger, W. Jerry
Sohl, Jessica
Freedman, Rachel A.
Sorensen, A. Gregory
Bullitt, Elizabeth
Harris, Gordon J.
Morganstern, Daniel
Schneider, Bryan P.
Krop, Ian E.
Winer, Eric P.
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Massachusetts Gen Hosp, Boston, MA 02114 USA
[3] Siemens Healthcare North Amer, Malvern, PA USA
[4] Univ N Carolina, Chapel Hill, NC USA
[5] Indiana Univ, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46204 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
513
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase II trial of carboplatin and bevacizumab in patients with breast cancer brain metastases
    Jose Pablo Leone
    Kyrre E. Emblem
    Michelle Weitz
    Rebecca S. Gelman
    Bryan P. Schneider
    Rachel A. Freedman
    Jerry Younger
    Marco C. Pinho
    A. Gregory Sorensen
    Elizabeth R. Gerstner
    Gordon Harris
    Ian E. Krop
    Daniel Morganstern
    Jessica Sohl
    Jiani Hu
    Elizabeth Kasparian
    Eric P. Winer
    Nancy U. Lin
    Breast Cancer Research, 22
  • [2] Phase II trial of carboplatin and bevacizumab in patients with breast cancer brain metastases
    Leone, Jose Pablo
    Emblem, Kyrre E.
    Weitz, Michelle
    Gelman, Rebecca S.
    Schneider, Bryan P.
    Freedman, Rachel A.
    Younger, Jerry
    Pinho, Marco C.
    Sorensen, A. Gregory
    Gerstner, Elizabeth R.
    Harris, Gordon
    Krop, Ian E.
    Morganstern, Daniel
    Sohl, Jessica
    Hu, Jiani
    Kasparian, Elizabeth
    Winer, Eric P.
    Lin, Nancy U.
    BREAST CANCER RESEARCH, 2020, 22 (01)
  • [3] Phase II trial of patupilone in patients (pts) with breast cancer brain metastases (BCBM) progressing or recurring after whole brain radiation therapy (WBXRT)
    Conlin, A. K.
    D'Andrea, G.
    Hudis, C. A.
    Robson, M. E.
    Drullinsky, P.
    Theodoulou, M.
    Lis, E.
    Kang, T. Y.
    Peereboom, D. M.
    Seidman, A. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [4] Phase II trial of gemcitabine, carboplatin, and bevacizumab (Bev) in patients (pts) with advanced/metastatic urothelial carcinoma (UC).
    Balar, A. V.
    Milowsky, M. I.
    Apolo, A. B.
    Ostrovnaya, I.
    Iasonos, A.
    Trout, A.
    Regazzi, A. M.
    Garcia-Grossman, I. R.
    Gallagher, D. J.
    Bajorin, D. F.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [5] A phase II study of cabozantinib (cabo) alone or in combination with trastuzumab (T) in patients (pts) with breast cancer brain metastases (BCBM)
    Leone, Jose Pablo
    Hu, Jiani
    Barry, William Thomas
    Duda, Dan G.
    Gerstner, Elizabeth Robins
    Jain, Rakesh K.
    Tan, Sally
    Lawler, Elizabeth S.
    Winer, Eric P.
    Lin, Nancy U.
    Tolaney, Sara M.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [6] New graded prognostic index for breast cancer patients (pts) with brain metastases (BCBM).
    Ahluwalia, Manmeet Singh
    Du, Lingling
    Venur, Vyshak Alva
    Angelov, Lilyana
    Chao, Samuel T.
    Elson, Paul
    Mohammadi, Alireza Mohammad
    Peereboom, David M.
    Budd, G. Thomas
    Barnett, Gene H.
    Suh, John H.
    Abraham, Jame
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [7] TBCRC 022: Phase II trial of neratinib for patients (Pts) with human epidermal growth factor receptor 2 (HER2+) breast cancer and brain metastases (BCBM).
    Freedman, Rachel A.
    Gelman, Rebecca Sue
    Wefel, Jeffrey Scott
    Krop, Ian E.
    Melisko, Michelle E.
    Lowe, Alarice
    Agar, Nathalie
    Blackwell, Kimberly L.
    Connolly, Roisin M.
    Niravath, Polly Ann
    Van Poznak, Catherine H.
    Puhalla, Shannon
    Ryabin, Nicole
    Lawler, Elizabeth S.
    Ibrahim, Nuhad K.
    Liu, Minetta C.
    Wolff, Antonio C.
    Winer, Eric P.
    Lin, Nancy U.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [8] TEMOZOLAMIDE AND PACLITAXEL OR CARBOPLATIN IN ADVANCED BREAST CANCER PATIENTS (PTS) WITH BRAIN METASTASES
    Blasi, L.
    Leonardi, V.
    Palmisano, V.
    Pepe, A.
    Savio, G.
    Rondello, G.
    Pindaro, L.
    Amoroso, G.
    Agostara, B.
    ANNALS OF ONCOLOGY, 2004, 15 : 24 - 25
  • [9] Phase II trial of GDC0084 in combination with trastuzumab for patients with HER2-positive breast cancer brain metastases (BCBM)
    Leone, Jose P.
    Trippa, Lorenzo
    Milisits, Lindsey
    Andrews, Chelsea
    Ligibel, Jennifer
    Parsons, Heather
    Bi, Wenya L.
    Zhao, Jean
    Winer, Eric P.
    Lin, Nancy U.
    CANCER RESEARCH, 2020, 80 (04)
  • [10] Phase II trial of patupilone in patients with breast cancer brain metastases
    Peereboom, David
    Brewer, Cathy
    Seidman, Andrew
    NEURO-ONCOLOGY, 2007, 9 (04) : 523 - 523
12345